PHP
MRUS

Parkman Healthcare Partners’s Merus MRUS Stock Holding History

Parkman Healthcare Partners’s Portfolio MRUS Stock Details MRUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-162,980
Closed -$8.57M – 97
2025
Q2 		$8.57M Buy
162,980
+134,750
+477% +$6.33M 0.99% 34
2025
Q1 		$1.19M Sell
28,230
-17,450
-38% -$761K 0.14% 82
2024
Q4 		$1.92M Buy
45,680
+331
+0.7% +$15.9K 0.26% 74
2024
Q3 		$2.27M Buy
45,349
+197
+0.4% +$10.3K 0.29% 72
2024
Q2 		$2.67M Sell
45,152
-34,971
-44% -$1.69M 0.36% 67
2024
Q1 		$3.61M Sell
80,123
-77,694
-49% -$3.15M 0.44% 67
2023
Q4 		$4.34M Buy
157,817
+27,082
+21% +$632K 0.61% 52
2023
Q3 		$3.08M Buy
130,735
+62,854
+93% +$1.52M 0.56% 51
2023
Q2 		$1.79M Buy
+67,881
New +$1.49M 0.31% 79

Other funds holding MRUS

PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Parkman Healthcare Partners's MRUS Position: Q3 2025 in Review

Parkman Healthcare Partners sold out of Merus (MRUS) in Q3 2025, closing a stake of 162,980 shares — an estimated $8.57M sold.

Parkman Healthcare Partners first reported a position in MRUS in Q2 2023 and held it in 9 quarters. The position peaked at $8.57M in Q2 2025. 268 funds tracked by Wall St. Rank hold MRUS as of Q3 2025.

  • Parkman Healthcare Partners reported no remaining Merus position as of Q3 2025 after selling out during the quarter.
  • Parkman Healthcare Partners sold 162,980 Merus shares in Q3 2025, an estimated $8.57M.
  • Parkman Healthcare Partners first reported a position in Merus in Q2 2023 and held it in 9 quarters.
  • Parkman Healthcare Partners's Merus position peaked at $8.57M in Q2 2025.
  • 268 funds tracked by Wall St. Rank held Merus as of Q3 2025.

Based on Parkman Healthcare Partners's 13F filing for Q3 2025, filed 14 Nov 2025.